On Monday, April 28th, clinical real-world data (RWD) company Atropos Health announced that it would be collaborating with community oncology real-world data (RWD) provider Ontada to enhance oncology data use cases for clinicians, researchers, and healthcare leaders — significantly increasing its ability to design care protocols, advance precision medicine, develop new oncology treatments, and more. This will be achieved through the installation of Atropos’ GENEVA OS™ into providers’ cloud data environments, along with access to the Atropos Evidence™ Network, which with over 300 million patient records is currently the largest federated healthcare data network. Access to GENEVA OS and the Atropos Evidence Network will allow providers to gain access to high-quality, relevant data for any question they have; data which has been evaluated using Atropos’ Real-World Fitness Score®.
Atropos Health CEO and co-founder Dr. Brigham Hyde shared as part of the company’s press release that “The demand for high-quality data in oncology is ever present…This collaboration with Ontada will help life sciences organizations accelerate the rate at which [real-world evidence] insights drive decision-making for drug discovery and development and ensure they are presented and acted upon, driving innovation and ultimately improving the lives of cancer patients.”
Christine Davis, President at Ontada, also expressed enthusiasm with the announcement. “Ontada and Atropos Health are committed to accelerating evidence generation to drive better outcomes for patients with cancer,” Davis said. “This collaboration will empower life sciences organizations by enhancing their evidence-generation capabilities and supporting more effective clinical decision-making that can help to improve patient care.”
Headquartered in Palo Alto, CA, and founded in 2020, Atropos Health has made a name for itself as a powerful force for real-world data and real-world evidence-based medicine. Founded as part of Mckesson in 2020, Ontada is an advanced oncology insights and technology provider located in Boston, MA. For more information regarding this announcement, read the press release below.
See related materials: